Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance

NAUnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

June 30, 2021

Conditions

Coronary Artery DiseaseCardiomyopathy

Interventions

DRUG

Cardiac MRI taken using contrast agent, Dotarem® (Gd-DOTA)

Gadolinium based contrast agent used in cardiac MRI scanning using 3.0 Tesla MRI

DRUG

Cardiac MRI with contrast agent, Gadovist

Brand of Gd-DO3A-butrol; contrast agent used in cardiac MRI scanning using 3.0 Tesla MRI